How do you choose 1st line therapy for recurrent cervical cancer?

Topics: Gynecologic Cancers • Cervical Cancer • Medical Oncology • Immunotherapy • ASCO Journal Club

Would you be more or less likely to use a cisplatin-containing regimen if a patient had previously responded to chemoradiation with concurrent cisplatin?

Answer from: at Academic Institution

I use the Moore criteria and if the score is greater than or equal to 2, I will evaluate the patient for contraindications to bevacizumab and if none, I will counsel her to receive bevacizumab plus chemotherapy. The chemotherapy backbone is cisplatin-paclitaxel if the patient did not receive cisplat...

Comments

Medical Oncologist at Texas Oncology-San Antonio Babcock
for pts with low PS and other comorbid illness, I ...

Related Questions